Scarica l'app Stockscreener
85.81
0.80%
0.68
Dopo l'orario di chiusura:
85.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALC Giù?
Forum
Previsione
Storia dei dividendi
Alcon Inc Borsa (ALC) Ultime notizie
Alcon (ALC) is a Top-Ranked Value Stock: Should You Buy? - Yahoo Canada Finance
Most Venture Investors Want Their Startups to Go Public. Not This One. - The Wall Street Journal
Alcon Laboratories is considering a major $100M expansion of its Fort Worth campus - AOL
Results: Alcon Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance
Reiterate Overweight on Alcon with $107 target post 3Q results - Investing.com
Alcon Inc. (NYSE:ALC) Q3 2024 Earnings Call Transcript - Insider Monkey
Alcon shares maintain Buy rating and $107 target post-results By Investing.com - Investing.com Australia
Alcon Stock: Q3, Slight Guidance Cut Is Not Something Structural (NYSE:ALC) - Seeking Alpha
Alcon Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours - Yahoo Finance
3 Focus Stocks: Alcon, Up Fintech, and Monolithic Power Systems - Baystreet.ca
ALCON : Q3 miss and an outlook downgrade should not be seen as worrisome - Marketscreener.com
Pharmaceuticals: Alcon records lower growth in the third quarter | blue News - bluewin E-Mail
Alcon cuts 2024 forecasts, as slow US hits surgical unit - MSN
Alcon Lowers Financial Outlook After US Sales Slump - Finimize
Alcon trims revenue forecast - 69News WFMZ-TV
Alcon shares maintain Buy rating and $107 target post-results - Investing.com
Alcon Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Alcon falls 6% as company trims 2024 sales outlook - MSN
Alcon Posts Higher 3Q Sales and Profit, Lowers 2024 Sales View - MarketWatch
Alcon’s Strong Q3 2024 Results Boost Investor Confidence - TipRanks
Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation - Yahoo Finance
Cell therapy startup's IPO plans thrown in limbo amid legal spat with investor Alcon - Endpoints News
Subdued Growth No Barrier To Alcon Inc.'s (VTX:ALC) Price - Simply Wall St
Tarsus Pharmaceuticals seesaws amid report Alcon interest has cooled - MSN
Alcon focuses on bringing high-quality innovations to China to address different consumers’ needs - Global Times
What Analyst Projections for Key Metrics Reveal About Alcon (ALC) Q3 Earnings - MSN
Alcon launches Precision7, a 1-week silicone hydrogel replacement contact lens - Healio
Customer-centricity takes the spotlight during clinical transformation - Medical Device Network
Alcon Announces the U.S. Launch of PRECISION®, the Only One-Week Replacement Contact Lens - Marketscreener.com
GLOBALink | CIIE's spillover effect boosts innovations, digitalization: Alcon China president - Xinhua
Alcon supporting optometry students through educational grant - Insight
Alcon upgraded to Hold from Reduce at Kepler Cheuvreux - TipRanks
Alcon Inc. (ALC): Among UBS’ Top Tech Based Disruptive Stocks For 2030 - Insider Monkey
Alcon Receives Prestigious Export Achievement Award - The BRAKE Report
Alcon (VTX:ALC) Might Have The Makings Of A Multi-Bagger - Simply Wall St
World Council of Optometry and Alcon Launch ‘WCO Alcon Dry Eye Wheel’ Tool in Spanish - Vision Monday
Alcon Singapore Elevates Associate Experience with Inspiring Engagement Programs - Yahoo Finance
Zeiss Callisto Digital Alignment System Superior to Alcon for Toric IOL Implantation - Physician's Weekly
Novartis To Buy Nestlé's 52% Stake In Alcon For $28.1 BlnUpdate - RTTNews
SightMD Introduces Advanced Alcon Topo-Guided Wavelight® Laser with Contoura® Vision to Enhance LASIK Eye Surgery Options - PR Web
Musk and Tesla Sued by 'Blade Runner 2049' Producers Over AI Image at Robotaxi Unveiling - Inc.
2024 Research | Europe Retinal Surgery Devices Market Poised for Growth, Expected to Reach $1.16 Billion by 2032, Driven by Rising Prevalence of Retinal Diseases and Technological Advancements - GlobeNewswire Inc.
Alcon sues Musk, Tesla for unauthorized 'Blade Runner' use | Daily Sabah - Daily Sabah
Elon Musk Faces Legal Challenge Over AI-Generated 'Blade Runner 2049' Imagery Use At 'We Robot' Event: Alcon Cites 'Highly Politicized, Capricious And Arbitrary Behavior' - Benzinga
Blade Runner 2049' Producer Joins Growing List of… - Inkl
‘Blade Runner 2049’ Producers Sue Elon Musk, Tesla and Warner Bros. Discovery, Alleging Copyright Infringement - Variety
Alcon Lighting Teams with Beverly Hills Police Department to Help Spread Awareness on Protecting Retail Stores with Lighting - The Malaysian Reserve
Blade Runner 2049 producers sue Elon Musk, Tesla, and Warner over AI-generated image used in Cybercab promotional event - PC Gamer
Returns On Capital Are Showing Encouraging Signs At Alcon (VTX:ALC) - Yahoo Finance
ABT: 3 Medical Device Stocks to Buy for Consistent Growth - StockNews.com
Alcon shares gain as KeyBanc raises target with Overweight rating - Investing.com
Alcon shares gain as KeyBanc raises target with Overweight rating By Investing.com - Investing.com Canada
Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance - Business Wire
Diabetes Associated Ophthalmic Treatment Market 2031 | Key Brands -Alcon, Johnson & Johnson Services, Inc., Bausch Healt – IndiaPolitics.com - IndiaPolitics.com
1.99%
2.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):